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Abstract
Objective—Delirium severity is independently associated with longer hospital stays, nursing 
home placement and death in patients outside the intensive care unit (ICU). Delirium severity in 
the ICU is not routinely measured because the available instruments are difficult to complete in 
critically ill patients. We designed our study to assess the reliability and validity of a new ICU 
delirium severity tool, the Confusion Assessment Method (CAM)-ICU-7 delirium severity scale.
Design—Observational cohort study.
Setting—Medical, surgical and progressive ICUs of three academic hospitals.
Patients—518 adult (≥18 years) patients.
Interventions—None.
Measurements and Main Results—Patients received the CAM-ICU, Richmond Agitation-
Sedation Scale (RASS), and Delirium Rating Scale-Revised (DRS-R)-98 assessments. A 7-point 
scale (0-7) was derived from responses to the CAM-ICU and RASS items. CAM-ICU-7 showed 
high internal consistency (Cronbach's alpha=0.85) and good correlation with DRS-R-98 scores 
(correlation coefficient=0.64). Known-groups validity was supported by the separation of 
mechanically ventilated and non-ventilated assessments. Median CAM-ICU-7 scores 
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demonstrated good predictive validity with higher odds (OR=1.47; 95% CI=1.30-1.66) of 
inhospital mortality, and lower odds (OR=0.8; 95% CI=0.72-0.9) of being discharged home after 
adjusting for age, race, gender, severity of illness, and chronic comorbidities. Higher CAM-ICU-7 
scores were also associated with increased length of ICU stay (p=0.001).
Conclusion—Our results suggest that CAM-ICU-7 is a valid and reliable delirium severity 
measure among ICU patients. Further research comparing it to other delirium severity measures, 
its use in delirium efficacy trials, and real life implementation is needed to determine its role in 
research and clinical practice.
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Delirium; ICU; CAM-ICU
Introduction
Delirium, sometimes referred to as acute brain failure, is characterized by altered 
consciousness with a reduced ability to focus, sustain, or shift attention that develops 
quickly and fluctuates over the course of the day.[1] Delirium is highly prevalent among 
critically ill patients;[2-6] and is associated with greater lengths of intensive care unit (ICU) 
and hospital stays, mortality, and cost of care.[3-5] Delirium severity has also been 
associated with adverse patient outcomes including higher risks of nursing home placement 
and mortality.[7-9] Delirium severity scores have been used in clinical settings and for 
conducting research outside the ICU,[10] but their use in the ICU have been restricted 
mostly to research. Measuring delirium severity in the ICU may not only fulfill a prognostic 
role for patients with delirium, but could also serve as a guide for successful therapeutic 
interventions.
Delirium Rating Scale-Revised-98 (DRS-R-98) is a widely used delirium severity scale 
advocated in the ICU setting given its strong psychometric properties.[11] Unfortunately 
DRS-R-98 use in the ICU has been limited by the inherent difficulty in implementing and 
interpreting it among mechanically ventilated patients due to the structure of its questions. 
Hence assessments performed through DRS-R-98 results in missing data, thus decreasing its 
clinical applicability. It also requires significant administration time and expert judgment on 
several of its items, thereby further restricting its use by untrained busy clinicians. An ICU 
delirium severity tool that can overcome these limitations would be ideally suited for the 
complex, chaotic ICU environment.
Indiana University Center for Aging Research conducted a randomized, clinical trial the 
“Pharmacological Management of Delirium (PMD)”[12] in which every enrolled patient 
underwent daily sedation, delirium and delirium severity assessments. The presence of these 
assessments allowed us to undertake the current study with the objective to develop a new 
delirium severity tool and to assess its reliability and validity.
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Methods
The Research Compliance Administration of Indiana University-Purdue University approved 
the study (Protocol#1010002428). Informed consent was obtained from patients’ legally 
authorized representatives.
Study Setting
Patients enrolled in the PMD trial and admitted to the ICU services of three Indianapolis 
hospitals (Wishard Memorial Hospital (WMH) now known as Eskenazi Health, University 
Hospital, and Methodist Hospital) from March 2009-January 2015 were included in the 
study. PMD is a National Institutes of Health funded clinical trial[12] testing the 
effectiveness of a multi-component intervention to reduce delirium duration and severity in 
the ICU. The details of the trial have been published elsewhere.[12] WMH is a 457-bed, 
university-affiliated, public hospital with three ICU units, an 8-bed surgical ICU (SICU), a 
14-bed medical ICU (MICU), and a 29-bed progressive (step-down) ICU (PICU). University 
hospital is a 257-bed tertiary care hospital with 36 MICU and SICU beds. Methodist hospital 
is an 802-bed tertiary care center with a 65-bed MICU/SICU.
Inclusion and Exclusion Criteria
Inclusion criteria: 1) admitted to the ICUs of WMH, University Hospital and Methodist 
Hospital; 2) age ≥18 years; and 3) had delirium based on Confusion Assessment Method for 
the ICU (CAM-ICU).[13] Exclusion criteria: 1) not English speaking; 2) hearing impaired; 
3) legally blind; 4) admitted with alcohol intoxication; 5) prisoners; 6) having an Axis 1 
Psychiatric disorder; or 7) pregnant/nursing.
Assessments
Richmond Agitation-Sedation Scale (RASS)[14] and the CAM-ICU[13] were used to assess 
patients’ sedation and delirium respectively. RASS has excellent inter-rater reliability (inter-
class correlation coefficient=0.956; k=0.73, 95% CI=0.71-0.75) and high validity.[14] CAM-
ICU has high criterion validity (sensitivity=97%, specificity=98%, accuracy=98.4%) and 
high inter-rater reliability (k=0.96, 95% CI=0.92-0.99).[13] Trained research assistants 
performed twice-daily RASS/CAM-ICU assessments. Patients with a RASS score of −4 (no 
response to voice, but movement or eye opening to physical stimulation) or −5 (no response 
to voice or physical stimulation) were ineligible for CAM-ICU assessments. Patients were 
considered delirious if they had a RASS greater than or equal to −3 (any response to verbal 
stimulation) and a positive CAM-ICU result, achieved by showing signs of acute change in 
mental status or fluctuating course, displaying features of inattention, and either 
disorganized thinking or altered level of consciousness.[13] Research assistants administered 
DRS-R-98 twice daily to assess delirium severity covering 24-hour period using information 
from family, nurses, doctors and medical charts.[11] DRS-R-98 is a 16-item scale with 13 
severity items; each rated from 0-3 with a maximum of 39 points with higher scores 
indicating greater delirium severity. DRS-R-98 assesses symptoms such as impairments in 
attention, short and long-term memory, visuospatial ability and orientation, perceptual and 
sleep-wake cycle disturbances, abnormalities of language, thought process and content, 
motor agitation/retardation, and mood lability. It has excellent inter-rater reliability (intra-
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class correlation=0.97) and internal consistency (Cronbach's α=0.94).[11] All the research 
assistants had bachelor's degree and one was an MD. Dr. Paula Trepacz, the developer of 
DRS-R-98 trained the research assistants on DRS-R-98 administration. The initial training 
consisted of didactics followed by as-needed consultations. Afterwards, Dr. Malaz Bosutani, 
an expert dementia and delirium researcher oversaw the training and quality control for 
DRS-R-98 administration and scoring.
Development of CAM-ICU-7 Delirium Severity Scale
A 7-point rating scale (0-7) was derived from the CAM-ICU and RASS assessments. The 
CAM-ICU items were further categorized as shown in Table 1. The scoring method was 
adapted from a prior study validating CAM-S as a delirium severity instrument outside the 
ICU setting.[10] CAM-ICU-7 maintained the same scoring scheme of CAM-S, but the 
scores were objectively derived based on the CAM-ICU and RASS items (Table 1). For 
acute onset, we could only create a binary outcome based on the definition. For inattention, 
disorganized thinking and altered level of consciousness, we conducted regression models 
with DRS-R-98 as the dependent variable and chose the cut-off points in each domain to 
maximize the correlation with DRS-R-98. The final CAM-ICU-7 score ranges from 0-7 with 
7 being most severe. CAM-ICU-7 scores were further categorized as 0-2: no delirium, 3-5: 
mild to moderate delirium, and 6-7: severe delirium.
Other Data and Clinical Outcomes
Baseline demographics such as age, gender, and race were collected. Patients’ chronic 
comorbidities were assessed using the Charlson comorbidity index.[15] The severity of 
acute illness was assessed using the Acute Physiology and Chronic Health Evaluation 
(APACHE) II scale.[16] Length of ICU and hospital stay, and in-hospital mortality data were 
collected from electronic medical records.
Statistical Analyses
Internal consistency-reliability was assessed using Cronbach's alpha. Pearson correlation 
coefficient was used to assess correlations between the CAM-ICU-7 and DRS-R-98 in the 
overall sample as well as in specific subgroups. We used Wilcoxon-Rank Sum tests to 
compare CAM-ICU-7 severity across known subgroups based on their mechanical 
ventilation status and age. Logistic regression analysis was used to assess the relationship of 
in-hospital mortality and discharge status with the CAM-ICU-7 (median, maximum) and 
DRS-R-98 (median) summary scores as well as delirium duration after adjusting for age, 
race, gender, Charlson comorbidity index and severity of illness. For assessments with 
missing items on the DRS-R-98, we imputed the total DRS-R-98 score if at least 50% of the 
thirteen scale items were completed. We calculated the total score by taking the mean of the 
completed items and multiplying by the total number of items on the DRS-R-98. Due to the 
skewed nature of the ICU length of stay (LOS) outcome, we used linear regression with the 
log (ICU LOS+1) for associations with CAM-ICU-7 severity measures adjusting for age, 
race, gender, Charlson comorbidity index and severity of illness. All analyses were 
conducted using SAS 9.4 software (SAS Institute Inc., Cary, NC, USA).
Khan et al. Page 4
Crit Care Med. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results
We included 518 delirious patients in the study. The mean age of the patients was 60.2 years 
(SD 16.1), 55% were females, 45% were African-Americans and 59% were mechanically 
ventilated (Table 2).
Internal Consistency-Reliability
We found high internal consistency-reliability of the CAM-ICU-7 scales (Cronbach's 
alpha=0.85). We performed sensitivity analyses by examining possible effects of race, 
gender, age, and mechanical ventilation. Cronbach's alpha was consistently high in various 
subgroups: 0.85 in African-Americans, 0.85 in Caucasians; 0.86 in females, 0.85 in males; 
0.86 in patients age <65 years, 0.83 in patients ≥65 years, and 0.83 among mechanically 
ventilated compared to 0.82 among non-ventilated.
Correlation of CAM-ICU-7 with DRS-R-98 (Construct Validity)
We completed 8,056 RASS and CAM-ICU assessments on 518 patients. Out of 8,056 RASS 
and CAM-ICU assessments, there were 5,120 assessments where DRS-R-98 scores were 
available (3,709 completed assessments, 1,411 assessments with at least seven completed 
items where the DRS-R-98 scores were imputed). CAM-ICU-7 scores correlated well with 
the 5,120 DRS-R-98 scores with a correlation coefficient of 0.64, hence demonstrating 
construct validity. The correlation coefficient was 0.67 for assessments with all completed 
DRS-R-98 items and 0.56 for assessments with imputed DRS-R-98 scores. The scores also 
correlated among mechanically ventilated (r=0.40) and non-ventilated assessments (r=0.66), 
although ventilated patients had higher DRS-R-98 missing values. The correlation 
coefficient was 0.66 for patients <65 years of age and 0.57 for those ≥65 years. 
Supplemental Digital Content – Figure 1 shows the average CAM-ICU-7 scores for number 
of items completed on DRS-R-98, demonstrating an inverse relationship between missing 
DRS-R-98 values and CAM-ICU-7 scores.
CAM-ICU-7 scores by clinical sub-groups (Known-Groups Validity)
CAM-ICU-7 scores were higher in assessments among mechanically ventilated patients 
[median=5 (IQR=2-7)], compared to non-ventilated assessments [median=0 (IQR=0-3)] 
(p<0.001). CAM-ICU-7 scores also increased with increasing age, median: [<50 years: 0 
(0-3), 50-64 years: 1 (0-4), ≥65 years: 2 (0-5)] (p<0.001).
Association of CAM-ICU-7 with clinical outcomes (Predictive Validity)
The median CAM-ICU-7 score from each patient during hospitalization was associated with 
an odds ratio (OR) of 1.47 (95% CI=1.30-1.66) (AUC=0.785) of in-hospital mortality after 
adjusting for age, race, gender, severity of illness, and chronic comorbidities. Similar results 
were obtained using the highest CAM-ICU-7 scores [OR=1.32 (1.11-1.57)] (AUC=0.731). 
In contrast, the logistic models using median DRS-R-98 scores or delirium duration 
provided lower AUCs [DRS-R-98=0.727 (p=0.06); delirium duration=0.685 (p=0.003)] for 
in-hospital mortality compared to using median CAM-ICU-7. For patients who did not die 
during the hospitalization (n=461), higher median CAM-ICU-7 scores during hospitalization 
were associated with lower odds [OR=0.8 (CI=0.72-0.9)] (AUC=0.747) of being discharged 
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home after adjusting for age, race, gender, severity of illness, and chronic comorbidities. 
Similarly highest CAM-ICU-7 scores were associated with lower odds of discharge to home 
[OR=0.78 (0.71-0.86)] (AUC=0.764). Table 3 shows the odds of in-hospital mortality and 
discharge to home associated with delirium severity (measured by CAM-ICU-7 and DRS-
R-98), and delirium duration. Supplemental Digital Content – Table 1 shows the logistic 
regression models for median CAM-ICU-7 scores associated with mortality and discharge to 
home compared with the median DRS-R-98 scores and delirium duration. Supplemental 
Digital Content – Figure 2 shows the receiver operating characteristics (ROC) for the median 
CAM-ICU-7 and delirium duration for mortality (2a) and discharge to home (2b) 
respectively. The median CAM-ICU-7 scores (p=0.001; partial r=0.145) and highest CAM-
ICU-7 scores (p<0.001; partial r=0.327) were also associated with longer length of ICU stay.
Sub-categorization of CAM-ICU-7 Scores
We categorized the CAM-ICU-7 scores as 0-2: no delirium, 3-5: mild to moderate delirium, 
and 6-7: severe delirium. After adjusting for age, race, gender, severity of illness and chronic 
comorbidities, patients with severe delirium had significantly higher odds of death 
(OR=2.92; CI=1.17-7.26, p=0.02) compared to those with mild to moderate delirium.
Discussion
Our results suggest that CAM-ICU-7 delirium severity scale is a valid, reliable and practical 
delirium severity measure that correlates with the currently available, validated delirium 
severity scale, the DRS-R-98. Further more, delirium severity as measured by the CAM-
ICU-7 scores significantly predicts the clinical outcomes of in-hospital mortality, discharge 
destination and length of ICU stay. Derived from the widely used RASS and CAM-ICU 
clinical tools, the CAM-ICU-7 delirium severity scale showed good test characteristics with 
a higher predictive validity for in-hospital mortality over delirium severity measured through 
the DRS-R-98 and over delirium duration.
In addition to its association with relevant clinical outcomes, the structure of the CAM-
ICU-7 offers certain practical elements that may allow easy incorporation into busy clinical 
practice. First and foremost is the absence of additional data collection. The data to calculate 
CAM-ICU-7 are already generated through the RASS and CAM-ICU assessments. The 
other advantage includes an objective ordinal score that could be followed over time to 
assess the efficacy of therapeutic measures in controlling delirium symptoms. Our project 
did not address the questions of implementation of the CAM-ICU-7 into the ICU and the 
efficacy of interventions to reduce delirium severity. Although with an increase in research 
to reduce delirium burden in the ICU, incorporation of a valid and practical delirium severity 
measure such as the CAM-ICU-7 will help in answering the aforementioned observations. 
Also use of short, practical tools in research studies will produce results that could be 
quickly and efficiently translatable to the clinical setting.
Currently, measurement of delirium severity in the ICU has been limited to research and is 
not a standard clinical practice. As mentioned above, this is largely due to the lack of brief, 
practical delirium severity scales along with absence of efficacious therapeutic agents for 
delirium symptoms. DRS-R-98 is a valid and reliable instrument for measurement of 
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delirium severity[11] that has been extensively used for research. Although it has strong 
psychometric properties[11] and covers the breadth of delirium symptoms, its use in the ICU 
has been limited. This is due to the amount of time required for administration, extensive 
training requirements, and the ICU specific clinical factors including severity of illness and 
mechanical ventilation that renders it difficult to complete DRS-R-98 assessments. This was 
evident in our patient population where mechanically ventilated patients had a large number 
of missing DRS-R-98 assessments. We found higher CAM-ICU-7 scores among patients 
with missing DRS-R-98 data, raising the question of underestimating severe delirium when 
symptoms cannot be assessed due to the inability to complete DRS-R-98 (Supplemental 
Digital Content – Figure 1). We also assessed whether deep sedation may artificially inflate 
delirium severity as measured through the CAM-ICU-7 but found similar distributions of 
higher delirium severity among both sedated and agitated assessments (Supplemental Digital 
Content – Figure 3).
Besides DRS-R-98, Delirium Detection Score (DDS),[17] Nursing Delirium Screening 
Scale (Nu-DESC),[18,19] and Intensive Care Delirium Screening Checklist (ICDSC)[20,21] 
have been used in critical care settings to assess delirium severity. These scales consist of 
items depicting various symptoms of delirium, which together form an overall score with 
higher scores representing higher severity.[17-21] DDS and Nu-DESC do not capture 
inattention, one of the cardinal features of delirium, whereas DDS has poor sensitivity, 
making it less desirable as a delirium screening tool.[19] Heavy workflow in the ICU with 
limited time for evaluation and documentation makes it impractical to use separate scales for 
assessment of delirium and its severity. The ICDSC captures inattention making it a suitable 
scale for both delirium identification and severity.[20, 21] ICDSC also evaluates sleep-wake 
cycle disturbances not evaluated by the CAM-ICU-7. Evaluating additional constructs is an 
advantage, but the information to generate ICDSC scoring is collected over 24 hours, which 
could lead to recall bias and over estimation of delirium severity.[22] CAM-ICU 
administration time of less than one minute[23] allows for more frequent administrations 
along with direct interaction with patients. This provides a higher reproducibility especially 
among the mechanically ventilated, as CAM-ICU-7 does not rely on observation alone. 
Future work comparing CAM-ICU-7 to ICDSC will help clarify which of the two 
instruments has the greatest utility to measure and follow delirium.
Both ICDSC and Nu-DESC can identify patients with subsyndromal delirium,[18,21] 
characterized by presence of one or more symptoms of delirium and associated with adverse 
clinical outcomes.[18,21] A critique of the CAM-ICU is that its dichotomous approach of 
detecting delirium and absence of ordinal grading of delirium severity symptoms could miss 
patients with lower delirium severity that may benefit from early interventions. This could 
potentially be mitigated by use of the CAM-ICU-7 that provides a graded scale for delirium 
severity assessment. As seen in our study, clinical outcomes vary between mild to moderate 
delirium and severe delirium. This is in contrast to ICDSC, which plateaus at the threshold 
of clinical delirium and does not provide further predictive discrimination. As our data were 
limited to delirious patients only, we were not able to identify subsyndromal delirium. 
Studies with both delirious and non-delirious patients will be able to clarify assessment of 
subsyndromal delirium using the CAM-ICU-7.
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Limitations: A) Inability of the CAM-ICU-7 to capture the entire symptom spectrum of 
delirium severity, compromising its construct validity. This should be evaluated in the 
context of feasibility versus validity. CAM-ICU-7 is easy to implement as it takes the same 
time as CAM-ICU that has been adopted internationally and is the most widely used 
delirium assessment scale in the ICU. In addition, we believe that CAM-ICU-7 captures the 
core cognitive constructs of delirium. B) We compared the CAM-ICU-7 with the DRS-R-98 
and not the gold-standard psychiatrist based assessment of delirium or with a validated ICU 
delirium severity scale such as the ICDSC. Although not validated specifically in the ICU, 
the DRS-R-98 has been utilized in the critical care setting[24] and is highly reliable and 
valid.[11] C) CAM-ICU-7 and DRS-R-98 assessments were performed by the same research 
assistants that could have led to a higher correlation. D) Research assistants performed the 
DRS-R-98, an instrument originally designed for psychiatrists. E) The timeframe between 
identifying delirious patients and study enrollment lasted up to 48 hours in some cases that 
could have resulted in missing highest severity assessments.
Our study has several strengths. We have a large and diverse sample with half of the patients 
being females and African Americans. Presence of both mechanically ventilated and non-
ventilated patients belonging to different age groups provide known-groups validity to the 
CAM-ICU-7 assessments. Highly trained research assistants performed twice-daily CAM-
ICU and DRS-R-98 assessments. Patients were recruited from three different hospitals with 
different case-mixes. We gave equal severity weight to both the hyper and hypoactive 
delirium based on RASS assessments. This mitigates the concern of mislabeling an 
intervention efficacious when it converts hyperactive agitated delirium to hypoactive 
delirium. This aspect will be beneficial both for clinical monitoring and conducting future 
research interventions.
Conclusions
The CAM-ICU-7 delirium severity scale is a valid, reliable, and practical delirium severity 
measure among ICU patients that can be easily calculated and is associated with meaningful 
clinical outcomes. This practical tool could improve the ability to correlate delirium severity 
with long-term complications, including cognitive impairment and healthcare resource 
utilization. Additionally, the CAM-ICU-7 may facilitate evaluation of delirium severity as an 
outcome of clinical trials attempting to reduce the burden of delirium in the ICU.
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Refer to Web version on PubMed Central for supplementary material.
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Table 1
The CAM-ICU-7 Delirium Severity Scale
CAM-ICU
Items Grading Score
1. Acute Onset or Fluctuation of Mental Status
Is the patient different than his/her baseline mental status?
OR
Has the patient had any fluctuation in mental status in the past 24 hours as evidenced by 
fluctuation on a sedation/level of consciousness scale (i.e., RASS/SAS), GCS, or previous 
delirium assessment?
0 absent
1 present
2. Inattention
Say to the patient, “I am going to read you a series of 10 letters. Whenever you hear the letter 
‘A,’ indicate by squeezing my hand.” Read letters from the following letter list in a normal tone 
3 seconds apart. SAVEAHAART (Errors are counted when patient fails to squeeze on the letter 
“A” and when the patient squeezes on any letter other than “A”)
0 absent (correct ≥ 8)
1 for inattention (correct 4-7)
2 for severe inattention (correct 
0-3)
3. Altered Level of Consciousness
Present if the Actual RASS score is anything other than alert and calm (zero)
0 absent (RASS 0)
1 for altered level (RASS 1, −1)
2 for severe altered level (RASS 
>1, < −1)
4. Disorganized Thinking
Yes/No Questions
1. Will a stone float on water?
2. Are there fish in the sea?
3. Does one pound weigh more than two pounds?
4. Can you use a hammer to pound a nail?
Errors are counted when the patient incorrectly answers a question.
Command: Say to patient “Hold up this many fingers” (Hold two fingers in front of patient). 
“Now do the same with the other hand” (Do not repeat number of fingers)
An error is counted if patient is unable to complete the entire command.
0 absent (correct ≥ 4)
1 for disorganized thinking 
(correct 2, 3)
2 for severe disorganized 
thinking (correct 0, 1)
Total Score
CAM-ICU: Confusion Assessment Method for the Intensive Care Unit; RASS: Richmond Agitation Sedation Scale; SAS: Sedation-Agitation 
Scale; GCS: Glasgow Coma Scale
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Table 2
Patients’ Characteristics
Patients’ Characteristics* (n: 518)
Age 60.2 (16.1)
Female n (%) 286 (55.2)
African-American n (%) 232 (45)
Mechanical ventilation n (%) 304 (58.7)
Education in years 11.4 (2.4)
Katz ADLa Scale 5.4 (1.4)
Lawton IADLb Scale 6.1 (2.6)
IQCODEc 3.2 (0.5)
APACHEd II 20 (8.2)
Charlson comorbidity Index 3.2 (2.8)
Delirium duration in days 3 (4.3)
Mechanical ventilation duration in days 4.0 (6.7)
Intensive care unit length of stay in days 14.4 (15.2)
Hospital length of stay in days 26.4 (34.1)
Discharged Home n (%) 189 (36.5)
Mortality n (%) 57 (11)
*
Data presented as means (SD) unless otherwise specified.
aActivities of daily living
b
Instrumental activities of daily living
c
Informant questionnaire on cognitive decline in elderly
dAcute physiology and chronic health evaluation score
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Table 3
Odds ratios (OR) of in-hospital mortality and discharge destination associated with delirium severity measured 
through CAM-ICU-7 and DRS-R-98, and delirium duration.
Variables In-Hospital Mortality
OR (95% CI)+ AUCc
Delirium Severity CAM-ICU-7a (n=518)* 1.47 (1.30 – 1.66) 0.785
DRS-R-98b (n=465)# 1.11 (1.04 – 1.17) 0.727
Delirium Duration (days) (n=518)* 1.05 (0.98 – 1.11) 0.685
Discharged Home
OR (95% CI) AUC
Delirium Severity CAM-ICU-7 (n=461)* 0.80 (0.72 – 0.90) 0.747
DRS-R-98 (n=434)# 0.92 (0.88 – 0.97) 0.743
Delirium Duration (days) (n=461)* 0.87 (0.82 – 0.93) 0.765
aCAM-ICU-7: Confusion Assessment Method for the Intensive Care Unit-7
b
DRS-R-98: Delirium Rating Scale Revised
cAUC: Area under the curve
*
Data from the whole cohort.
#
Data from patients in whom DRS-R-98 was calculated.
+
Models adjusted for age, gender, race, severity of illness, and chronic co-morbidities
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